-
OYST Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
Oyster Point Pharma (OYST)
Company Profile
Quarter (USD) | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 68.80 mm | 68.80 mm | 68.80 mm | 68.80 mm | 68.80 mm | 68.80 mm |
Cash burn (monthly) | 12.05 mm | 9.62 mm | 11.30 mm | 13.20 mm | 11.99 mm | 13.83 mm |
Cash used (since last report) | 323.04 mm | 257.96 mm | 303.16 mm | 354.11 mm | 321.55 mm | 370.97 mm |
Cash remaining | -254.24 mm | -189.16 mm | -234.36 mm | -285.31 mm | -252.75 mm | -302.17 mm |
Runway (months of cash) | -21.1 | -19.7 | -20.7 | -21.6 | -21.1 | -21.8 |
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 0 |
Closed positions | 55 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 68.56 mm |
Total shares | 5.93 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
New Enterprise Associates 14 | 5.93 mm | $68.56 mm |
Versant Venture Capital VI | 0.00 | $0.00 |
InvOpps IV US | 0.00 | $0.00 |